Lipschitz Gregory 4

What Happened
Gregory Lipschitz, CEO of Firefly Neuroscience (AIFF), had 65,988 restricted stock units (RSUs) vest on March 10, 2026. The Form 4 reports an acquisition of 65,988 shares at a reported price of $0.00 (award/vesting), reflecting performance-based vesting from a prior grant.

Key Details

• Transaction date: March 10, 2026; filing date: March 12, 2026 (no late-file notation on the Form 4).
• Transaction type/code: A (award/grant/acquisition via vesting of RSUs); price shown $0.00.
• Shares acquired/vested: 65,988 shares.
• Shares owned after transaction: Reporting person directly owns 65,988 shares; through Bower Four Capital Corporation (of which he is the sole stockholder) he is associated with 464,196 shares, for 530,184 total reported shares.
• Notable footnotes: RSUs were originally granted April 18, 2025 under the issuer’s 2024 Long-Term Incentive Plan for 395,927 shares; the Compensation Committee determined on March 10, 2026 that performance conditions were met for vesting of 65,988 of those shares. The reporting person disclaims beneficial ownership of the shares held by Bower Four except to the extent of pecuniary interest.

Context
This transaction is a vesting of performance-based RSUs (an award), not a market purchase or sale; the reported acquisition price of $0.00 means no cash was paid to receive these shares. Such vesting reflects fulfillment of plan conditions and does not by itself indicate the insider’s intent to buy or sell shares in the open market.